Investors in Neurocrine Biosciences, Inc. NBIX need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 15, 2024 $80.00 Call had some of the highest...
"Rule Breaker Investing" Market Cap Game Show: Throwdowns & Long-Term Wins
Motley Fool analysts Matt Argersinger and Yasser El-Shimy face off.
According to analysts, here are three top-notch mid-cap growth stocks to snag at a discount now.
Why Neurocrine Biosciences Stock Was Tumbling This Week
The company promises to advance a top investigational drug to late-stage testing, but investors might not think that's a fine idea.
New Study Reveals How Classical Music Could Revolutionize Depression Care
In a groundbreaking study, Chinese scientists have revealed that classical music could be a powerful tool in the fight against treatment-resistant depression, a condition that affects nearly 50% of patients...